Avapritinib

Basic Information

Item Value
DrugBank ID DB15233
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 axial spondylometaphyseal dysplasia KG + DL
2 bilateral parasagittal parieto-occipital polymicrogyria KG + DL
3 amyotrophic lateral sclerosis KG + DL
4 trichomegaly-retina pigmentary degeneration-dwarfism syndrome KG + DL
5 amyotrophic lateral sclerosis, susceptibility to KG + DL
6 amyotrohpic lateral sclerosis type 22 KG + DL
7 lower motor neuron syndrome with late-adult onset KG + DL
8 lethal arthrogryposis-anterior horn cell disease syndrome KG + DL
9 monomelic amyotrophy KG + DL
10 Mills syndrome KG + DL
11 autosomal dominant mitochondrial myopathy with exercise intolerance KG + DL
12 familial generalized lentiginosis KG + DL
13 rhabdoid tumor KG + DL
14 gastrocutaneous syndrome KG + DL
15 congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome KG + DL
16 acromelanosis KG + DL
17 Moynahan syndrome KG + DL
18 osteopathia striata-pigmentary dermopathy-white forelock syndrome KG + DL
19 leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome KG + DL
20 peripheral nerve schwannoma KG + DL
21 sympathetic neurilemmoma KG + DL
22 schwannoma of twelfth cranial nerve KG + DL
23 trigeminal schwannoma KG + DL
24 microcystic/reticular schwannoma KG + DL
25 benign PEComa KG + DL
26 lymphangiomyoma KG + DL
27 uterine corpus perivascular epithelioid cell tumor KG + DL
28 dermatofibrosarcoma protuberans KG + DL
29 liposarcoma KG + DL
30 ovarian myxoid liposarcoma KG + DL
31 extracutaneous mastocytoma KG + DL
32 neurocutaneous melanocytosis KG + DL
33 neurofibromatosis KG + DL
34 autosomal recessive familial Mediterranean fever KG + DL
35 lung PEComa KG + DL
36 lymphangioleiomyomatosis KG + DL
37 familial rhabdoid tumor KG + DL
38 neuroectodermal melanolysosomal disease KG + DL
39 familial caudal dysgenesis KG + DL
40 heart fibrosarcoma KG + DL
41 fibroblastic neoplasm KG + DL
42 conventional fibrosarcoma KG + DL
43 kidney fibrosarcoma KG + DL
44 laterality defects, autosomal dominant KG + DL
45 heart position anomaly KG + DL
46 low grade fibromyxoid sarcoma KG + DL
47 situs inversus KG + DL
48 vulva sarcoma KG + DL
49 cryptogenic organizing pneumonia KG + DL
50 familial Mediterranean fever, autosomal dominant KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.